Private equity giant KKR (NYSE:KKR) put another $235 million into EchoNous, the parent company of Signostics, for the second time in as many years. The cash is earmarked for commercializing the Uscan ultrasound device, developing a vein-location device and an unnamed artificial intelligence-driven ultrasound project to market, Seattle-based EchoNous said. KKR put $35 million into the company […]
Avedro CEO Muller is out | Personnel Moves
Avedro said CEO David Muller stepped down shortly after it closed a $32 million equity round last month, replaced on an interim basis by COO Brian Roberts, the former CFO at Insulet (NSDQ:PODD). Waltham-based Avedro said Muller left to “pursue other opportunities.” “On behalf of the board and all the Avedro employees, I want to thank […]
Cardiac Dimensions taps ex-AccessClosure chief Casciaro for CEO | Personnel Moves
Cardiac Dimensions said this week that it tapped the former chief of AccessClosure, Gregory Casciaro, to be its new president & CEO. Casciaro led AccessClosure until its May 2014 acquisition by Cardinal Health (NYSE:CAH) for $320 million. His résumé includes stints as the chief executive at drug-eluting stent maker Xtent, Orquest (acquired JNJ’s DePuy Acromed in 2003) […]
Private equity giant KKR puts $35m into Signostics
Signostics said it landed $35 million from private equity giant KKR (NYSE:KKR) for its handheld ultrasound technology. “KKR offers us the privilege of working with a highly regarded long-term capital partner which will enable us to create next-level innovations and beyond, aimed at greater disruption and democratization of the global ultrasound market,” CEO Kevin Goodwin, who […]
NuVasive promotes GC Hannon to int’l EVP | Personnel Moves
NuVasive Inc. (NSDQ:NUVA) said today it promoted general counsel Jason Hannon to international executive vice president, where he will head the company’s international expansion. Hannon, who has been with the company since 2005, will relocate to Amsterdam to lead the company’s international efforts, NuVasive said. Hannon was promoted to executive VP of corporate development and general counsel in 2010. “We […]
Philips taps ex-Hologic CEO Cascella to lead imaging biz | Personnel Moves
Signostics wins FDA go-ahead for handheld ultrasound device
Australian medical device company Signostics won 510(k) approval for its handheld ultrasound device.
The device will be sold as the Sonimage P3 through the its partnership with Konica Minolata (TYO:4902). This device already is on the market in Europe and Australia, where it is sold as Signos RT.